Exploring the neuroregenerative potential of tacrolimus

Area of Science:

• Neuroscience
• Immunology
• Regenerative Medicine

Background:

• Tacrolimus (FK506) is clinically used but presents neurotoxicity.
• Paradoxically, tacrolimus also demonstrates neuroregenerative properties.
• Understanding its molecular mechanisms is key to elucidating neurobiological effects.

Purpose of the Study:

• To review current evidence on tacrolimus in peripheral nerve injuries.
• To elucidate molecular mechanisms behind conflicting neurotoxic and neuroregenerative effects.
• To discuss clinical applications and delivery concepts.

Main Methods:

• Literature review of available data on tacrolimus indications.
• Elucidation of molecular mechanisms of action.
• Discussion of experimental models and clinical applications.

Main Results:

• Tacrolimus' mechanism involves calcineurin inhibition and binding to FK506-binding protein-52, showing a bimodal dose response.
• Preferred administration timing in experimental models is within 3 days pre- or 10 days post-nerve reconstruction.
• Expanding indications include dermatology, ophthalmology, orthopedic surgery, and rheumatology.

Conclusions:

• The exact neurobiological effects of tacrolimus remain unclear.
• Tacrolimus shows potential as an immunosuppressant and nerve regeneration enhancer in peripheral nerve injuries.
• Further research is needed to optimize its clinical use and delivery.